Bob G. Gower - 23 Jun 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role: Director, 10%+ Owner
Signature: /s/ Bob G Gower
Issuer symbol: ENSC
Transactions as of: 23 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2022, 17:40:22 UTC
Previous filing: 04 Feb 2022
Next filing: 01 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENSC	Common Stock						7,919,026	23 Jun 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENSC	Stock Option	Award		+15,000	+56%		41,585	23 Jun 2022	Common Stock	15,000	$0.4250	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 23, 2022, Mr. Gower was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year.